Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

Authors :: Y. Demizu
Tomoaki Okimoto
Kazuki Terashima
Yasue Niwa
Dongcun Jin
Kuniaki Katsui
Nobukazu Fuwa
Masayuki Mima
M. Murakami
Masaru Takagi
Fumiko Nagano
T. Waki
Osamu Fujii
Nor Shazrina Sulaiman
Source :: International Journal of Radiation Oncology*Biology*Physics. 96:E263
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
medicine.disease
Androgen deprivation therapy
Prostate cancer
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Intermediate risk
business
Proton therapy

Full Text Access

Tools